São Paulo - Delayed Quote BRL

T4F Entretenimento S.A. (SHOW3.SA)

2.5100

-0.0100

(-0.40%)

At close: April 22 at 5:00 PM GMT-3

Smartphone upgrade: The two features consumers focus on most

If you're in the market for a new smartphone, perhaps due to an unfortunate incident or simply desiring to trade in your personal device for the latest generation, CNET Senior Editor Lisa Eadicicco joins Wealth! to share insights on factors to consider when upgrading your smartphone. Eadicicco highlights two aspects consumers prioritize when selecting a new phone, beyond a comfortable budget: screen size and camera capabilities. She emphasizes that these are the two features consumers tend to utilize the most, stating "they're two factors you can't really change." Additionally, Eadicicco outlines several considerations when choosing a network provider, including exploring better deals, evaluating coverage in your area, and even testing out the carrier's service before fully committing. For more expert insight and the latest market action, click here to watch this full episode of Wealth! This post was written by Angel Smith

Yahoo Finance Video 17 hours ago

TMUS

SSNLF

VZ
Spotify's monthly user numbers miss estimates on lower promotions

Spotify on Tuesday reported quarterly monthly active users (MAU) of 615 million, missing its own estimates, as the Swedish music streaming company spent less on marketing activities to draw in more listeners. First-quarter MAUs rose 19%, but missed Spotify's own guidance and a median of analysts' forecasts of 618 million. Premium subscribers, who account for most of the company's revenue, rose by 14% to 239 million, in line with estimates, according to IBES data from LSEG.

Reuters 7 minutes ago

SPOT
Spotify Technology S.A. Releases Financial Results for First Quarter 2024

NEW YORK, April 23, 2024--Spotify Technology S.A. (NYSE: SPOT) has released its financial results for the first quarter of 2024 today. Please visit investors.spotify.com to view the Shareholder Deck and other supplemental materials.

Business Wire 17 minutes ago

SPOT
AB Foods Eyes Further Profit Growth as Primark Margins Rise

Primark owner AB Foods raised its dividend and said it expects a significant rise in full-year profit after its budget retailer delivered robust margins and higher earnings.

The Wall Street Journal 1 hour ago

ASBFF

ASBFY
Stocks to Watch Tuesday: Tesla, Tapestry, Cadence Design Systems

↘️ **Tesla (TSLA**): All eyes are on the EV maker's earnings, due after the market close. Tesla stock edged up in premarket trading, after a rocky stretch that has seen it fall over 40% in 2024. 🔎 Earnings are due from **General Motors (GM)**, **PepsiCo (PEP)**, **Philip Morris (PM)**, **Spotify (SPOT)** and **UPS (UPS)** ahead of the market open.

The Wall Street Journal 1 hour ago

SAP

SAPGF

NVS
Trending tickers: Tesla, ABF, Novartis, Taylor Wimpey, JD Sports

The latest investor updates on stocks that are trending on Tuesday.

Yahoo Finance UK 1 hour ago

ASBFF

ASBFY

^FTSE
UPDATE 1-Healthcare, tech stocks boost STOXX 600 to one-week high

European stocks scaled to their highest levels in more than a week on Tuesday, driven by the healthcare and technology sector, as investors found comfort in upbeat corporate earnings, while the UK's FTSE 100 Index climbed to hit an all-time peak. The pan-European STOXX 600 index was up 0.6%, as of 0838 GMT, boosted by a nearly 0.9% jump in healthcare stocks .

Reuters 1 hour ago

^FTSE

TITR.MI

NVS
These Stocks Are Moving the Most Today: Tesla, GE Aerospace, Cadence Design Systems, Calix, Nucor, Hibbett, and More

Tesla has closed lower for seven straight sessions but the stock rises ahead of its first-quarter earnings report scheduled for after markets close Tuesday. GE Aerospace, General Motors, UPS, Lockheed Martin, and PepsiCo also report earnings Tuesday.

Barrons.com 1 hour ago

NUE

CDNS

TSLA
Primark owner sees profits soar as it hails stronger business conditions

Associated British Foods said consumers remain under some pressure from the cost-of-living crisis.

PA Media: Money 1 hour ago

ASBFY

WNGPF
Is Verizon a Good Dividend Stock to Buy Now?

A 17-year payout-raising streak and a dividend yield above 6% make this a hard stock to ignore right now.

Motley Fool 1 hour ago

VZ
SAP Rises Most Since January on Record Cloud Backlog Growth

(Bloomberg) -- SAP SE rose the most since January after posting record growth in expected revenue from its cloud services over the next year, boosted by the boom in artificial intelligence. Most Read from BloombergRay Dalio’s Famous Trade Is Sputtering, Investors BailingTrump Has Only $6.8 Million for Legal Fees With Trial UnderwayZimbabwe’s ZiG Wipes Out 330% Stocks RallyRussians Transform Dubai as They Flee Putin’s War: Photo EssaySea Billionaire’s Wife to Buy Singapore Mansion for $31 Million

Bloomberg 1 hour ago

SAP
Novartis Raises Guidance on Profit, Sales Growth

Novartis lifted its full-year guidance after first-quarter profit and sales rose and beat consensus expectations, boosted by strong sales of key drugs.

The Wall Street Journal 2 hours ago

NVS

NVSEF
Three Leading Growth Stocks With Insider Ownership Exceeding 11%

In the past year, the United States stock market has shown resilience with a 19% increase, despite a recent 7-day dip of 3.2%. In this environment, growth companies with high insider ownership can be particularly compelling, as such ownership often signals confidence in the company's future prospects from those who know it best.

Simply Wall St. 2 hours ago

EL

SE

PDD
Cadence Design Systems Inc (CDNS) Q1 2024 Earnings Call Transcript Highlights: Robust Financial ...

Unveiling a record Q1 backlog and optimistic full-year financial outlook amidst technological transitions and market adaptations.

GuruFocus.com 3 hours ago

CDNS
Verizon Communications Inc (VZ) Q1 2024 Earnings Call Transcript Highlights: Strong Wireless ...

Explore key financial outcomes and strategic insights from Verizon's Q1 2024 earnings, featuring robust subscriber additions and significant wireless service revenue growth.

GuruFocus.com 3 hours ago

VZ
Techs boost STOXX to one-week high; euro zone data on tap

European stocks scaled on Tuesday to their highest levels in more than a week, driven by the technology sector as investors found comfort in upbeat corporate earnings, while UK's FTSE 100 Index climbed to hit an all-time peak. The pan-European STOXX 600 index was up 0.6%, as of 0712 GMT, boosted by a nearly 2% jump in technology shares.

Reuters 3 hours ago

^FTSE

NVS
UPDATE 4-Novartis raises guidance after beating Q1 expectations

Swiss drugmaker Novartis raised its full-year guidance on wider use of psoriasis and arthritis drug Cosentyx on Tuesday and said it had tapped the former boss of Bristol Myers Squibb (BMS) to become its chairman next year. It expects its 2024 net sales to grow by a high-single to low double-digit percentage with adjusted operating income growing by a low double-digit to mid-teens percentage, Novartis said in a statement. It has previously predicted that adjusted operating income would increase by a "high single-digit" percentage with "mid single-digit" sales growth.

Reuters 4 hours ago

NVS
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised

Ad hoc announcement pursuant to Art. 53 LRQ1 net sales grew +11% (cc1, +10% USD) with core operating income up +22% (cc, +16% USD) Key growth drivers continued strong sales momentum including Entresto (+36% cc), Cosentyx (+25% cc), Kesimpta (+66% cc), Kisqali (+54% cc), Pluvicto (+47% cc) and Leqvio (+139% cc)Core operating income margin 38.4%, +340 basis points (cc), mainly driven by higher net salesOperating income grew +39% (cc, +29% USD) and net income grew +37% (cc, +25% USD), mainly driven

GlobeNewswire 5 hours ago

NVS

NVSEF
Q1 2024 Verizon Communications Inc. Earnings Call

Q1 2024 Verizon Communications Inc. Earnings Call

Thomson Reuters StreetEvents 6 hours ago

VZ
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

CULVER CITY, Calif., April 23, 2024--ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has approved ANKTIVA (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.

Business Wire 8 hours ago

IBRX

Performance Overview

Return	SHOW3.SA	IBOVESPA
YTD	+18.96%	-6.42%
1-Year	+70.75%	+20.32%
3-Year	-37.56%	+4.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

T4F Entretenimento S.A. (SHOW3.SA)

Related News

Smartphone upgrade: The two features consumers focus on most

Spotify's monthly user numbers miss estimates on lower promotions

Spotify Technology S.A. Releases Financial Results for First Quarter 2024

AB Foods Eyes Further Profit Growth as Primark Margins Rise

Stocks to Watch Tuesday: Tesla, Tapestry, Cadence Design Systems

Trending tickers: Tesla, ABF, Novartis, Taylor Wimpey, JD Sports

UPDATE 1-Healthcare, tech stocks boost STOXX 600 to one-week high

These Stocks Are Moving the Most Today: Tesla, GE Aerospace, Cadence Design Systems, Calix, Nucor, Hibbett, and More

Primark owner sees profits soar as it hails stronger business conditions

Is Verizon a Good Dividend Stock to Buy Now?

SAP Rises Most Since January on Record Cloud Backlog Growth

Novartis Raises Guidance on Profit, Sales Growth

Three Leading Growth Stocks With Insider Ownership Exceeding 11%

Cadence Design Systems Inc (CDNS) Q1 2024 Earnings Call Transcript Highlights: Robust Financial ...

Verizon Communications Inc (VZ) Q1 2024 Earnings Call Transcript Highlights: Strong Wireless ...

Techs boost STOXX to one-week high; euro zone data on tap

UPDATE 4-Novartis raises guidance after beating Q1 expectations

Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised

Q1 2024 Verizon Communications Inc. Earnings Call

ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Performance Overview